ArticlebioRxiv : the preprint server for biology2024
Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model.
Emily Z Huie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.